Abstract
The various therapeutic methods applied to acute leukemia undoubtedly alter the leukemic cells as well as the normal cells. Marrow megaloblastosis was seen, as had been anticipated, as soon as antifolic agents were employed 20 years ago, and it has been known for a long time that the classification of a leukemic cell as a lymphoblast or myeloblast, often easy at the beginning, is totally impossible when treatment has been started [152]. On the whole, however, any attempts at analysis of these changes have been disappointing and have either ended up by being suspended or have been continued in a listless fashion.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Editor information
Rights and permissions
Copyright information
© 1969 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Bernard, J., Paul, R., Boiron, M., Jacquillat, C., Maral, R. (1969). Cytological and Immunological Study of Acute Leukemia Treated with Rubidomycin. In: Bernard, J., Paul, R., Boiron, M., Jacquillat, C., Maral, R. (eds) Rubidomycin. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 20. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-88125-1_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-88125-1_13
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-88127-5
Online ISBN: 978-3-642-88125-1
eBook Packages: Springer Book Archive